Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $100.16 USD
Change Today -0.74 / -0.73%
Volume 1.5M
MJN On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

mead johnson nutrition co (MJN) Snapshot

Open
$100.10
Previous Close
$100.90
Day High
$100.62
Day Low
$99.81
52 Week High
02/27/15 - $105.45
52 Week Low
04/23/14 - $84.02
Market Cap
20.3B
Average Volume 10 Days
970.0K
EPS TTM
$3.54
Shares Outstanding
202.5M
EX-Date
03/12/15
P/E TM
28.3x
Dividend
$1.65
Dividend Yield
1.54%
Current Stock Chart for MEAD JOHNSON NUTRITION CO (MJN)

mead johnson nutrition co (MJN) Details

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for the use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfamil A+, and Enfalac A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease and Enfamil A.R names. The company also provides specialty formula products, including formulas for addressing various conditions or special medical needs, such as cow’s milk protein and multiple other food allergies, premature and low birth weight infants, and premature babies at home, as well as produces medical foods for nutritional management of individuals under the Nutramigen, Puramino, Enfamil Premature, and EnfaCare. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in North America, Europe, Asia, and Latin America. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

7,700 Employees
Last Reported Date: 02/27/15
Founded in 1905

mead johnson nutrition co (MJN) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $1.0M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $551.0K
Senior Vice President of Technical Operations
Total Annual Compensation: $407.5K
Compensation as of Fiscal Year 2014.

mead johnson nutrition co (MJN) Key Developments

Mead Johnson Nutrition Company Announces Resignation of Tom De Weerdt, Vice President and Corporate Controller, Effective May 18, 2015

On April 17, 2015, Mead Johnson Nutrition Company announced that Tom De Weerdt, Vice President and Corporate Controller, informed the company on April 14, 2015 that he intends to leave the company to pursue another opportunity, effective May 18, 2015.

Mead Johnson Nutrition Company Announces Management Changes, Effective March 13, 2015

Mead Johnson Nutrition Company announced that Peter G. Leemputte, it's executive vice president and chief financial officer, has decided to leave the company for personal reasons. Effective March 13, 2015, he will transition his responsibilities to Charles Urbain. Urbain, currently the chief development officer, will serve as interim CFO until a permanent replacement is named. Leemputte will be available to assist in the transition through June 30, 2015. Leemputte has been with Mead Johnson since September 2008. He oversees the company's accounting and reporting, financial planning, audit, tax, treasury, investor relations and information technology functions. Urbain has been with the company for 28 years and has held a variety of senior line management positions. Among other roles, he has led the company's business in each of its regions, including Asia, and served as its chief financial officer when Mead Johnson was still a division of Bristol-Myers Squibb. As chief development officer, Urbain is currently responsible for key administrative functions, including external business development, corporate communications and human resources.

Mead Johnson Nutrition Company Appoints Michael A. Sherman as Director and Member of Audit Committee

On February 26, 2015, the board of directors of Mead Johnson Nutrition Company (the company) appointed Michael A. Sherman, effective immediately, to fill the vacancy created by the increase in the number of directors. Upon recommendation of the Nominating and Corporate Governance Committee, the board also appointed Mr. Sherman to serve as a member of the company's audit committee. Mr. Sherman currently serves as the chief operating officer and chief financial officer of Endocyte Inc. He has served as Endocyte's chief financial officer since 2006, and was also appointed as the chief operating officer in 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MJN:US $100.16 USD -0.74

MJN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biostime International Holdings Ltd $35.55 HKD -0.40
Inner Mongolia Yili Industrial Group Co Ltd CNY35.39 CNY -0.12
Perrigo Co PLC $198.98 USD -0.02
Hain Celestial Group Inc/The $64.01 USD -1.17
Yakult Honsha Co Ltd ¥7,810 JPY -250.00
View Industry Companies
 

Industry Analysis

MJN

Industry Average

Valuation MJN Industry Range
Price/Earnings 28.3x
Price/Sales 4.6x
Price/Book 35.3x
Price/Cash Flow 28.2x
TEV/Sales 3.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEAD JOHNSON NUTRITION CO, please visit www.meadjohnson.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.